GLYCOSTEM-THERAPEUTICS B.V.
Kloosterstraat 9 Kamer Re 1134 – Oss – 5349 AB
VAT: NL817989481B01
www.glycostem.nl
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, GLYCOSTEM-THERAPEUTICS B.V. has received € 255,374.0 for its participation in a total of 1 project(s) with a total cost of € 3,347,488.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-06-01 | 765104 | MATURE-NK | pharmaceutical drugs · oncology · personalized medicine · business and management · cells technologies | 2022-11-30 | participant | € 255,374.28 | € 3,347,488 | 1 | 14 | CORDIS ↪ |
GLYCOSTEM-THERAPEUTICS B.V. did not participate in complicit projects under Horizon Europe (2021-2027).
Within the FP7 (2007-2013) framework, GLYCOSTEM-THERAPEUTICS B.V. has received € 236,861.0 for its participation in a total of 1 project(s) with a total cost of € 3,526,286.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-10-01 | 317013 | NATURIMMUN | inflammatory diseases · genetic engineering · stem cells · oncology · immunotherapy | 2016-09-30 | participant | € 236,861.46 | € 3,526,286 | 1 | 11 | CORDIS ↪ |